Ayesha Junaid, a final-year MBBS student at Dow Medical College, shared on LinkedIn:
“Personalized cancer vaccines may be one of the next major frontiers in immuno-oncology.
Elad Sharon discusses neoantigen vaccines, PD-1 therapy, and why scientific rigor still matters.”
Other articles about immuno-oncology on OncoDaily.